Cargando…

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both

Detalles Bibliográficos
Autores principales:	Tezval, Hossein, Braesen, Jan Hinrich, Kuczyk, Markus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948128/ https://www.ncbi.nlm.nih.gov/pubmed/33582832 http://dx.doi.org/10.1007/s00345-021-03624-6

Ejemplares similares

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
por: Mazdak, Mehrdad, et al.
Publicado: (2021)

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
por: Tezval, Hossein, et al.
Publicado: (2009)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor
por: Pringle, Sarah, et al.
Publicado: (2020)

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
por: Anand, Kartik, et al.
Publicado: (2020)

Valuation of knowledge and ignorance in mesolimbic reward circuitry
por: Charpentier, Caroline J., et al.
Publicado: (2018)

Spider silk erectile nerve reconstruction in robot-assisted radical prostatectomy: a first-in-men feasibility analysis
por: Harke, Nina N., et al.
Publicado: (2023)

Ignoring Non-ignorable Missingness
por: Rabe-Hesketh, Sophia, et al.
Publicado: (2022)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2019)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Fake science and the knowledge crisis: ignorance can be fatal
por: Hopf, Henning, et al.
Publicado: (2019)

Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
por: Chen, Li, et al.
Publicado: (2022)

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019)

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
por: Tang, Qing, et al.
Publicado: (2022)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
por: Zhou, Yanting, et al.
Publicado: (2023)

Ignorism
por: Trüeb, Ralph Michel
Publicado: (2023)

Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature
por: Kramer, Mario W., et al.
Publicado: (2012)

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Schubert, Philipp, et al.
Publicado: (2020)

Subclinical Acute Kidney Injury Is Acute Kidney Injury and Should Not Be Ignored
por: Koyner, Jay L.
Publicado: (2020)

Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes
por: Chen, Li, et al.
Publicado: (2022)

Is it reasonable to ignore vitamin D status for musculoskeletal health?
por: Mason, Rebecca S, et al.
Publicado: (2020)

Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint
por: Konieczny, Magdalena, et al.
Publicado: (2020)

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Thuru, Xavier, et al.
Publicado: (2022)

PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
por: Tang, Quanying, et al.
Publicado: (2023)

Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment
por: Serratì, Simona, et al.
Publicado: (2023)

A small circle of knowledge, a large circle of ignorance.
por: Alexander, M
Publicado: (1995)

Embodied Irrationality? Knowledge Avoidance, Willful Ignorance, and the Paradox of Autonomy
por: Arfini, Selene, et al.
Publicado: (2021)

Psychoanalytic contributions in distinguishing willful ignorance and rational knowledge avoidance
por: Kam, Christopher
Publicado: (2023)

Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
por: Skalniak, Lukasz, et al.
Publicado: (2017)

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis
por: Schneider, Stephanie, et al.
Publicado: (2017)

A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy
por: Li, Siqi, et al.
Publicado: (2020)

Ignoring steroids
por: Van Epps, Heather L.
Publicado: (2006)

Ignoring endotoxin
por: Van Epps, Heather L.
Publicado: (2006)

Ignore the Hype
por: Perry, Brian
Publicado: (2020)

The encyclopaedia of ignorance
por: Weston-Smith, M, et al.
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_d23tqvdfkjt33v2de0lfl9nbc4